Metformin response predicts disease progression
Mon, 27 Mar 2006 07:26 PM EST
... NEW YORK (Reuters Health) - In type 2 diabetes patients who are treated with metformin alone, those who achieve low levels of glycosylated hemoglobin level (HbA1c), a common measure of blood sugar, in the first year have a longer period of drug effectiveness, investigators report. ...
Related Topics
- Disaster Response
- Metformin
- Emergency Preparedness & Response
- Rosiglitazone and Metformin
- Diseases & Conditions
- Glyburide and Metformin
- Glipizide and Metformin
- Heart Disease
- Bone Disease
- Lung Diseases & Disorders
- Huntington's Disease
- Kidney Disease
- Relaxation Response
- Rare Diseases
- Crohn's Disease
- Graves' Disease
- Autoimmune Diseases
- Periodontal Disease
- Cardiovascular Diseases And Disorders
- Liver Disease

Not Signed In -


